doi:10.1007/s10067-007-0746-3
because rigorously controlled human safety data specific to the TB-500 fragment does not exist, its longer-term risk profile, including possible immune reactions, remains unknown Evidence snapshot: Evidence for TB-500 itself is preclinical, drawn mainly from cell-culture and animal studies (a 1999 rat wound-healing study and later rodent cardiac- and tendon-injury models), with a 2026 scoping review describing the musculoskeletal literature on thymosin beta-4 and TB-500 as sparse and largely preclinical
As a result, it enhances tissue regeneration, reduces fibrosis (scar formation), and promotes healing in joints, skin, and muscles
Its cell-turnover mechanism is unmatched by any peptide
Calcium (with Vitamin D) Calcium is vital for bone health, nerve conduction, and cellular signaling